These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

620 related items for PubMed ID: 11799176

  • 1. Segregation of CD4 and CXCR4 into distinct lipid microdomains in T lymphocytes suggests a mechanism for membrane destabilization by human immunodeficiency virus.
    Kozak SL, Heard JM, Kabat D.
    J Virol; 2002 Feb; 76(4):1802-15. PubMed ID: 11799176
    [Abstract] [Full Text] [Related]

  • 2. Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells.
    Popik W, Alce TM, Au WC.
    J Virol; 2002 May; 76(10):4709-22. PubMed ID: 11967288
    [Abstract] [Full Text] [Related]

  • 3. Raft localization of CXCR4 is primarily required for X4-tropic human immunodeficiency virus type 1 infection.
    Kamiyama H, Yoshii H, Tanaka Y, Sato H, Yamamoto N, Kubo Y.
    Virology; 2009 Mar 30; 386(1):23-31. PubMed ID: 19178925
    [Abstract] [Full Text] [Related]

  • 4. Dynamic reorganization of chemokine receptors, cholesterol, lipid rafts, and adhesion molecules to sites of CD4 engagement.
    Nguyen DH, Giri B, Collins G, Taub DD.
    Exp Cell Res; 2005 Apr 01; 304(2):559-69. PubMed ID: 15748900
    [Abstract] [Full Text] [Related]

  • 5. HIV-1 entry into T-cells is not dependent on CD4 and CCR5 localization to sphingolipid-enriched, detergent-resistant, raft membrane domains.
    Percherancier Y, Lagane B, Planchenault T, Staropoli I, Altmeyer R, Virelizier JL, Arenzana-Seisdedos F, Hoessli DC, Bachelerie F.
    J Biol Chem; 2003 Jan 31; 278(5):3153-61. PubMed ID: 12431990
    [Abstract] [Full Text] [Related]

  • 6. Roles of CD4 and coreceptors in binding, endocytosis, and proteolysis of gp120 envelope glycoproteins derived from human immunodeficiency virus type 1.
    Kozak SL, Kuhmann SE, Platt EJ, Kabat D.
    J Biol Chem; 1999 Aug 13; 274(33):23499-507. PubMed ID: 10438529
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Blocking of HIV-1 infection by targeting CD4 to nonraft membrane domains.
    Del Real G, Jiménez-Baranda S, Lacalle RA, Mira E, Lucas P, Gómez-Moutón C, Carrera AC, Martínez-A C, Mañes S.
    J Exp Med; 2002 Aug 05; 196(3):293-301. PubMed ID: 12163558
    [Abstract] [Full Text] [Related]

  • 10. Coreceptor competition for association with CD4 may change the susceptibility of human cells to infection with T-tropic and macrophagetropic isolates of human immunodeficiency virus type 1.
    Lee S, Lapham CK, Chen H, King L, Manischewitz J, Romantseva T, Mostowski H, Stantchev TS, Broder CC, Golding H.
    J Virol; 2000 Jun 05; 74(11):5016-23. PubMed ID: 10799575
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Human immunodeficiency virus type 1 Nef associates with lipid rafts to downmodulate cell surface CD4 and class I major histocompatibility complex expression and to increase viral infectivity.
    Alexander M, Bor YC, Ravichandran KS, Hammarskjöld ML, Rekosh D.
    J Virol; 2004 Feb 05; 78(4):1685-96. PubMed ID: 14747534
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. CCR5, CXCR4, and CD4 are clustered and closely apposed on microvilli of human macrophages and T cells.
    Singer II, Scott S, Kawka DW, Chin J, Daugherty BL, DeMartino JA, DiSalvo J, Gould SL, Lineberger JE, Malkowitz L, Miller MD, Mitnaul L, Siciliano SJ, Staruch MJ, Williams HR, Zweerink HJ, Springer MS.
    J Virol; 2001 Apr 05; 75(8):3779-90. PubMed ID: 11264367
    [Abstract] [Full Text] [Related]

  • 17. New cholesterol-specific antibodies remodel HIV-1 target cells' surface and inhibit their in vitro virus production.
    Beck Z, Balogh A, Kis A, Izsépi E, Cervenak L, László G, Bíró A, Liliom K, Mocsár G, Vámosi G, Füst G, Matko J.
    J Lipid Res; 2010 Feb 05; 51(2):286-96. PubMed ID: 19654424
    [Abstract] [Full Text] [Related]

  • 18. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts.
    Nguyen DH, Hildreth JE.
    J Virol; 2000 Apr 05; 74(7):3264-72. PubMed ID: 10708443
    [Abstract] [Full Text] [Related]

  • 19. Cytolysis by CCR5-using human immunodeficiency virus type 1 envelope glycoproteins is dependent on membrane fusion and can be inhibited by high levels of CD4 expression.
    LaBonte JA, Madani N, Sodroski J.
    J Virol; 2003 Jun 05; 77(12):6645-59. PubMed ID: 12767984
    [Abstract] [Full Text] [Related]

  • 20. Human immunodeficiency virus type 1 Nef protein modulates the lipid composition of virions and host cell membrane microdomains.
    Brügger B, Krautkrämer E, Tibroni N, Munte CE, Rauch S, Leibrecht I, Glass B, Breuer S, Geyer M, Kräusslich HG, Kalbitzer HR, Wieland FT, Fackler OT.
    Retrovirology; 2007 Oct 01; 4():70. PubMed ID: 17908312
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.